Roche Holding AG
The new price was enough to get both sides to the table, said the source, who was not authorized to speak to the press.
Roche and Genentech declined to comment.
(Reporting by Jessica Hall; editing by Jeffrey Benkoe)
(For more M&A news and our DealZone blog, go to http://www.reuters.com/investing/news/mergers)